Obesity and natriuretic peptides in the PORTHOS study

9 May 2026 (08:00 - 12:45)

Organised by:

Sign in for access options

Sign in for access options

About the speaker

Professor Rui Baptista

ULS Entre Douro e Vouga, Santa Maria da Feira (Portugal)

4 More presentations in this session

Presentation thumbnail

Randomized, double-blind, placebo-controlled, safety, tolerability, PK, PD and exploratory efficacy phase 1b/2a trial with AC01 in patients with HFrEF

Professor L. Lund (Stockholm, SE)

Presentation thumbnail

Utilisation of guideline-directed medical therapy in the GRASP-HF study: patterns across acute and ambulatory heart failure settings

Professor O. Chioncel (Bucharest, RO)

Presentation thumbnail

Impact of EHR-based nudges or pharmacy services on GDMT prescribing in patients with HFrEF

Professor E. Wright (Danville, US)

Presentation thumbnail

POSEIDON: prevalence of high inflammatory risk in heart failure across the ejection fraction spectrum

Professor C. Lam (Singapore, SG)

Access the full session

Session thumbnail

Advances in heart failure detection and therapy

The Event

Event poster

Heart Failure 2026

9 May - 12 May 2026

You may be interested in

Congress Presentation

Should we screen for heart failure in patients with obesity, and how?

Congress Presentation

Optimizing NT-proBNP diagnostic performance in the patient with obesity

Congress Session

Biomarkers definning pathophysiology and prognosis

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources